Health Biotchnology Price To Sales vs. Net Asset
| SBHIX Fund | USD 24.65 0.05 0.20% |
For Health Biotchnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Health Biotchnology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Health Biotchnology Portfolio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Health Biotchnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Health Biotchnology Portfolio over time as well as its relative position and ranking within its peers.
Health |
Health Biotchnology Net Asset vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Health Biotchnology's current stock value. Our valuation model uses many indicators to compare Health Biotchnology value to that of its competitors to determine the firm's financial worth. Health Biotchnology Portfolio is rated second largest fund in price to sales among similar funds. It is rated third largest fund in net asset among similar funds making up about 15,840,000 of Net Asset per Price To Sales. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Biotchnology's earnings, one of the primary drivers of an investment's value.Health Net Asset vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Health Biotchnology |
| = | 0.75 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Health Biotchnology |
| = | 11.88 M |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Health Net Asset Comparison
Health Biotchnology is currently under evaluation in net asset among similar funds.
Health Biotchnology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Health Biotchnology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Health Biotchnology will eventually generate negative long term returns. The profitability progress is the general direction of Health Biotchnology's change in net profit over the period of time. It can combine multiple indicators of Health Biotchnology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.
Health Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Health Biotchnology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Health Biotchnology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Health Biotchnology's important profitability drivers and their relationship over time.
Use Health Biotchnology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Health Biotchnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will appreciate offsetting losses from the drop in the long position's value.Health Biotchnology Pair Trading
Health Biotchnology Portfolio Pair Trading Analysis
The ability to find closely correlated positions to Health Biotchnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Health Biotchnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Health Biotchnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Health Biotchnology Portfolio to buy it.
The correlation of Health Biotchnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Health Biotchnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Health Biotchnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Health Biotchnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Health Biotchnology position
In addition to having Health Biotchnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Health Mutual Fund
To fully project Health Biotchnology's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Health Biotchnology at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Health Biotchnology's income statement, its balance sheet, and the statement of cash flows.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |